Chinese health authorities said that as of 5 p.m. April 6th, the country had reported a total of 20 H7N9 cases, including six that have ended in fatalities. In case of human infection with the H7N9 avian influenza, BGI actively  participated in the study of virus and immediately open the emergency channel. Currently, BGI has established a rapid detection platform, can detect sample accurately within 36 hours. BGI also build a Genome Database of influenza and major infectious diseases, it can make timely response to a variety of public health emergencies.
The progress of E.coli outbreak in Germany was reported by media. BGI sequenced the genome of E. coli isolate within three days, using the Ion Torrent Personal Genome Machine and in less than a week, researchers found that the strain belonged to an enteroaggregative E. coli lineage containing genes for Shiga toxin 2 and resistant to several types of antibiotics. The research was published online in the New England Journal of Medicine.

After acquiring the samples of SARS on April 15, 2003, BGI completed the first genome sequence of SARS virus within 36 hours, identified the proteome of SARS virus within 48 hours, and developed the first generation of test kit for detecting SARS virus. 300,000  test kits, after obtaining the national approval of production, were immediately produced and donated for clinical application. During this event, BGI made great contribution to the battle against SARS, as well as displaying the overall advantage of BGI technology platforms when responding to emergencies.

On April 20, 2003, Chairman Jintao Hu visited BGI and highly acknowledged the achievement of BGI against SARS.



Tel:  400-706-6615(Sequencing)





Facebook: BGI

Twitter: BGI_Events

Address: Beishan Industrial Zone, Yantian District, Shenzhen, 518083, China